{"id":44661,"date":"2025-07-21T15:46:16","date_gmt":"2025-07-21T15:46:16","guid":{"rendered":"https:\/\/www.cfh.de\/?post_type=project&#038;p=44661"},"modified":"2025-07-28T17:00:19","modified_gmt":"2025-07-28T17:00:19","slug":"tgfs-bioncart","status":"publish","type":"project","link":"https:\/\/www.cfh.de\/en\/project\/tgfs-bioncart\/","title":{"rendered":"TGFS BIONCaRT GmbH"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8220;1&#8243; specialty=&#8220;on&#8220; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; width=&#8220;100%&#8220; max_width=&#8220;100%&#8220; module_alignment=&#8220;center&#8220; inner_width=&#8220;100%&#8220; inner_max_width=&#8220;80%&#8220; custom_padding=&#8220;||0px|||&#8220; animation_style=&#8220;slide&#8220; animation_direction=&#8220;bottom&#8220; animation_duration=&#8220;300ms&#8220; animation_delay=&#8220;50ms&#8220; animation_intensity_slide=&#8220;5%&#8220; animation_starting_opacity=&#8220;10%&#8220; animation_speed_curve=&#8220;ease-in&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;3_4&#8243; specialty_columns=&#8220;3&#8243; _builder_version=&#8220;4.16&#8243; custom_padding=&#8220;|||&#8220; global_colors_info=&#8220;{}&#8220; custom_padding__hover=&#8220;|||&#8220;][et_pb_row_inner _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; width=&#8220;100%&#8220; max_width=&#8220;80%&#8220; max_width_tablet=&#8220;100%&#8220; max_width_phone=&#8220;100%&#8220; max_width_last_edited=&#8220;on|tablet&#8220; module_alignment=&#8220;left&#8220; custom_padding=&#8220;0px||||false|false&#8220; animation_direction=&#8220;bottom&#8220; module_alignment_tablet=&#8220;center&#8220; module_alignment_phone=&#8220;&#8220; module_alignment_last_edited=&#8220;on|tablet&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column_inner saved_specialty_column_type=&#8220;3_4&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_image src=&#8220;https:\/\/www.cfh.de\/wp-content\/uploads\/2025\/07\/BionCart-Header-scaled.png&#8220; alt=&#8220;TGFS_header&#8220; title_text=&#8220;BionCart Header&#8220; force_fullwidth=&#8220;on&#8220; _builder_version=&#8220;4.16.1&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_image][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; width=&#8220;80%&#8220; width_tablet=&#8220;100%&#8220; width_phone=&#8220;&#8220; width_last_edited=&#8220;on|tablet&#8220; animation_direction=&#8220;bottom&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column_inner saved_specialty_column_type=&#8220;3_4&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_text _builder_version=&#8220;4.16.1&#8243; _module_preset=&#8220;default&#8220; header_font=&#8220;Noto Sans|700|||||||&#8220; header_text_color=&#8220;#495A66&#8243; header_font_size=&#8220;22px&#8220; header_2_font=&#8220;Noto Sans||||||||&#8220; header_2_text_color=&#8220;#6E95B2&#8243; header_2_font_size=&#8220;20px&#8220; header_3_font=&#8220;Noto Sans||||||||&#8220; header_3_text_color=&#8220;#495A66&#8243; header_4_font=&#8220;Noto Sans||||||||&#8220; header_4_text_color=&#8220;#6E95B2&#8243; header_4_font_size=&#8220;20px&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h4><span style=\"color: #9cc007;\">Chem-\/Biotech<\/span><\/h4>\n<h1>Innovative, allogene Zelltherapien zur Regeneration von gesch\u00e4digtem Knorpelgewebe<\/h1>\n<h2><span style=\"color: #9cc007;\">BIONCaRT GmbH<\/span><\/h2>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8220;4.16.1&#8243; _module_preset=&#8220;default&#8220; text_font=&#8220;Noto Sans||||||||&#8220; text_text_color=&#8220;#495A66&#8243; text_font_size=&#8220;17px&#8220; custom_margin=&#8220;-3px|||||&#8220; text_font_size_tablet=&#8220;&#8220; text_font_size_phone=&#8220;14px&#8220; text_font_size_last_edited=&#8220;on|phone&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<p>Die BIONCaRT GmbH ist ein Life-Science-Unternehmen, das an einer klinischen Studie der Phase I\/IIa zur Marktzulassung eines humanen Stammzelltherapeutikums zur Behandlung von fokalen Knorpelsch\u00e4den am Kniegelenk arbeitet. Die aus dem Nabelschnurgewebe extrahierten Stammzellen werden in eine kollagenhaltige Tr\u00e4germatrix eingebettet. In einem minimalinvasiven Eingriff setzt ein Chirurg die zellbeladene Matrix in den gesch\u00e4digten Knorpel ein. Das Zelltherapeutikum regt die Neubildung von Knorpelgewebe an und lindert Schmerzen und Entz\u00fcndung. Die Vision des Unternehmens ist es, k\u00fcnftig auch weitere Gelenke und andere Indikationen wie Arthrose mit innovativen Zelltherapien zu adressieren und so die Lebensqualit\u00e4t vieler Menschen deutlich zu verbessern.<\/p>\n<p>Der TGFS ist seit 2024 am Unternehmen beteiligt. Weitere Investoren sind bm|t sowie private Investoren.<\/p>\n<p>[\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][et_pb_column type=&#8220;1_4&#8243; _builder_version=&#8220;4.16&#8243; custom_padding=&#8220;|||&#8220; global_colors_info=&#8220;{}&#8220; custom_padding__hover=&#8220;|||&#8220;][et_pb_image src=&#8220;https:\/\/www.cfh.de\/wp-content\/uploads\/2025\/07\/Logo-BionCart.png&#8220; alt=&#8220;Tech &#038; Life Solutions GmbH&#8220; title_text=&#8220;Logo BionCart&#8220; align=&#8220;center&#8220; _builder_version=&#8220;4.16.1&#8243; _module_preset=&#8220;default&#8220; width=&#8220;100%&#8220; max_width=&#8220;100%&#8220; max_width_tablet=&#8220;60%&#8220; max_width_phone=&#8220;60%&#8220; max_width_last_edited=&#8220;on|desktop&#8220; custom_margin=&#8220;10%||30%||false|false&#8220; custom_margin_tablet=&#8220;||0%||false|false&#8220; custom_margin_phone=&#8220;&#8220; custom_margin_last_edited=&#8220;on|phone&#8220; animation_direction=&#8220;bottom&#8220; hover_enabled=&#8220;0&#8243; global_colors_info=&#8220;{}&#8220; sticky_enabled=&#8220;0&#8243;][\/et_pb_image][et_pb_text _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; text_font=&#8220;Noto Sans||||||||&#8220; text_text_color=&#8220;#495A66&#8243; text_font_size=&#8220;17px&#8220; custom_margin=&#8220;|||10%|false|false&#8220; custom_margin_tablet=&#8220;|||0%|false|false&#8220; custom_margin_phone=&#8220;&#8220; custom_margin_last_edited=&#8220;on|tablet&#8220; animation_direction=&#8220;bottom&#8220; text_orientation_tablet=&#8220;center&#8220; text_orientation_phone=&#8220;&#8220; text_orientation_last_edited=&#8220;on|tablet&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<p><strong>Status<\/strong><br \/>Aktiv<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; text_font=&#8220;Noto Sans||||||||&#8220; text_text_color=&#8220;#495A66&#8243; text_font_size=&#8220;17px&#8220; custom_margin=&#8220;|||10%|false|false&#8220; custom_margin_tablet=&#8220;|||0%|false|false&#8220; custom_margin_phone=&#8220;&#8220; custom_margin_last_edited=&#8220;on|tablet&#8220; animation_direction=&#8220;bottom&#8220; text_orientation_tablet=&#8220;center&#8220; text_orientation_phone=&#8220;&#8220; text_orientation_last_edited=&#8220;on|tablet&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<p><strong>Segment<\/strong><br \/>Fr\u00fchphase<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8220;4.16.1&#8243; _module_preset=&#8220;default&#8220; text_font=&#8220;Noto Sans||||||||&#8220; text_text_color=&#8220;#495A66&#8243; text_font_size=&#8220;17px&#8220; custom_margin=&#8220;|||10%|false|false&#8220; custom_margin_tablet=&#8220;|||0%|false|false&#8220; custom_margin_phone=&#8220;&#8220; custom_margin_last_edited=&#8220;on|tablet&#8220; animation_direction=&#8220;bottom&#8220; text_orientation_tablet=&#8220;center&#8220; text_orientation_phone=&#8220;&#8220; text_orientation_last_edited=&#8220;on|tablet&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<p><strong>Sitz\u00a0<\/strong><br \/>Grimma<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8220;4.16.1&#8243; _module_preset=&#8220;default&#8220; text_font=&#8220;Noto Sans||||||||&#8220; text_text_color=&#8220;#495A66&#8243; text_font_size=&#8220;17px&#8220; link_font=&#8220;Noto Sans||||||||&#8220; link_text_color=&#8220;#9CC007&#8243; custom_margin=&#8220;|||10%|false|false&#8220; custom_margin_tablet=&#8220;|||0%|false|false&#8220; custom_margin_phone=&#8220;&#8220; custom_margin_last_edited=&#8220;on|tablet&#8220; animation_direction=&#8220;bottom&#8220; text_orientation_tablet=&#8220;center&#8220; text_orientation_phone=&#8220;&#8220; text_orientation_last_edited=&#8220;on|tablet&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<p><strong>Website<br \/><\/strong><span style=\"color: #9cc007;\"><a href=\"https:\/\/bioncart.com\/en\/start\/\" target=\"_blank\" rel=\"noopener\" style=\"color: #9cc007;\">www.bioncart.com<\/a><\/span><\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8220;4.16.1&#8243; _module_preset=&#8220;default&#8220; text_font=&#8220;Noto Sans||||||||&#8220; text_text_color=&#8220;#495A66&#8243; text_font_size=&#8220;17px&#8220; link_font=&#8220;Noto Sans||||||||&#8220; link_text_color=&#8220;#9CC007&#8243; custom_margin=&#8220;|||10%|false|false&#8220; custom_margin_tablet=&#8220;|||0%|false|false&#8220; custom_margin_phone=&#8220;&#8220; custom_margin_last_edited=&#8220;on|tablet&#8220; animation_direction=&#8220;bottom&#8220; text_orientation_tablet=&#8220;center&#8220; text_orientation_phone=&#8220;&#8220; text_orientation_last_edited=&#8220;on|tablet&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<p><strong>TGFS-Team<\/strong><span style=\"color: #9cc007;\"><br \/><span style=\"color: #9cc007;\"><a href=\"https:\/\/www.cfh.de\/tgfs-team\/oliver-latz\">Oliver Latz<\/a><br \/><span style=\"color: #9cc007;\"><a href=\"https:\/\/www.cfh.de\/tgfs-team\/tobias-voigt\/\">Tobias Voigt<\/a><\/span><\/span><\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; width=&#8220;100%&#8220; max_width=&#8220;80%&#8220; max_width_tablet=&#8220;100%&#8220; max_width_phone=&#8220;100%&#8220; max_width_last_edited=&#8220;on|tablet&#8220; module_alignment=&#8220;center&#8220; custom_padding=&#8220;0px||0px||false|false&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_row column_structure=&#8220;1_2,1_2&#8243; module_class=&#8220;tablet-two-cols phone-two-cols&#8220; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; width=&#8220;100%&#8220; max_width=&#8220;59%&#8220; max_width_tablet=&#8220;80%&#8220; max_width_phone=&#8220;&#8220; max_width_last_edited=&#8220;on|tablet&#8220; module_alignment=&#8220;left&#8220; custom_margin_tablet=&#8220;5%||||false|false&#8220; custom_margin_phone=&#8220;&#8220; custom_margin_last_edited=&#8220;on|tablet&#8220; module_alignment_tablet=&#8220;center&#8220; module_alignment_phone=&#8220;&#8220; module_alignment_last_edited=&#8220;on|tablet&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;1_2&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_button button_url=&#8220;@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjMyNTYyIn19@&#8220; button_text=&#8220;zur \u00dcbersicht&#8220; button_alignment=&#8220;left&#8220; button_text_tablet=&#8220;zur \u00dcbersicht&#8220; button_text_phone=&#8220;\u00dcbersicht&#8220; button_text_last_edited=&#8220;on|tablet&#8220; module_class=&#8220;mobile-two-cols button_left&#8220; _builder_version=&#8220;4.16&#8243; _dynamic_attributes=&#8220;button_url&#8220; _module_preset=&#8220;default&#8220; custom_button=&#8220;on&#8220; button_text_size=&#8220;17px&#8220; button_text_color=&#8220;#495A66&#8243; button_border_width=&#8220;0px&#8220; button_font=&#8220;|700|||||||&#8220; button_icon=&#8220;&#x34;||divi||400&#8243; button_icon_placement=&#8220;left&#8220; button_on_hover=&#8220;off&#8220; custom_padding=&#8220;||||false|false&#8220; button_text_size_tablet=&#8220;&#8220; button_text_size_phone=&#8220;17px&#8220; button_text_size_last_edited=&#8220;on|desktop&#8220; button_bg_color_tablet=&#8220;&#8220; button_bg_color_phone=&#8220;&#8220; button_bg_color_last_edited=&#8220;on|desktop&#8220; global_colors_info=&#8220;{}&#8220; button_bg_color__hover_enabled=&#8220;on|hover&#8220; button_bg_color__hover=&#8220;#FFFFFF&#8220; button_bg_enable_color__hover=&#8220;on&#8220; custom_css_main_element_last_edited=&#8220;on|desktop&#8220;][\/et_pb_button][\/et_pb_column][et_pb_column type=&#8220;1_2&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_button button_url=&#8220;https:\/\/bioncart.com\/en\/start\/&#8220; url_new_window=&#8220;on&#8220; button_text=&#8220;zum Unternehmen&#8220; button_alignment=&#8220;right&#8220; button_text_tablet=&#8220;zum Unternehmen&#8220; button_text_phone=&#8220;Unternehmen&#8220; button_text_last_edited=&#8220;on|tablet&#8220; _builder_version=&#8220;4.16.1&#8243; _module_preset=&#8220;default&#8220; custom_button=&#8220;on&#8220; button_text_size=&#8220;17px&#8220; button_text_color=&#8220;#495A66&#8243; button_border_width=&#8220;0px&#8220; button_font=&#8220;|700|||||||&#8220; button_icon=&#8220;&#x35;||divi||400&#8243; button_on_hover=&#8220;off&#8220; button_text_size_tablet=&#8220;&#8220; button_text_size_phone=&#8220;17px&#8220; button_text_size_last_edited=&#8220;on|tablet&#8220; global_colors_info=&#8220;{}&#8220; button_bg_color__hover_enabled=&#8220;on|hover&#8220; button_bg_color__hover=&#8220;RGBA(0,0,0,0)&#8220; button_bg_enable_color__hover=&#8220;on&#8220;][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u201eDie BIONCaRT GmbH ist ein Life-Science-Unternehmen mit Sitz in Grimma, das von Dr. Andr\u00e9 Gerth gegr\u00fcndet wurde. Das Unternehmen arbeitet an einer klinischen Studie der Phase I\/IIa zur Marktzulassung eines humanen Stammzelltherapeutikums zur Behandlung von fokalen Knorpelsch\u00e4den am Kniegelenk. Die aus dem Nabelschnurgewebe extrahierten Stammzellen werden in eine kollagenhaltige Tr\u00e4germatrix eingebettet. In einem minimalinvasiven Eingriff setzt ein Chirurg die zellbeladene Matrix in den gesch\u00e4digten Knorpel ein. Das Zelltherapeutikum regt die Neubildung von Knorpelgewebe an und lindert Schmerzen und Entz\u00fcndung.<br>\nDie Vision des Unternehmens ist es, k\u00fcnftig auch weitere Gelenke und andere Indikationen wie Arthrose mit innovativen Zelltherapien zu adressieren und so die Lebensqualit\u00e4t vieler Menschen deutlich zu verbessern.\u201c<\/p>","protected":false},"author":5,"featured_media":44703,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_custom_body_class":"","_custom_post_class":"","wp_typography_post_enhancements_disabled":false,"footnotes":""},"project_category":[21],"project_tag":[],"class_list":["post-44661","project","type-project","status-publish","has-post-thumbnail","hentry","project_category-tgfs"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>TGFS BIONCaRT GmbH - CFH<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cfh.de\/en\/project\/tgfs-bioncart\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TGFS BIONCaRT GmbH - CFH\" \/>\n<meta property=\"og:description\" content=\"\u201eDie BIONCaRT GmbH ist ein Life-Science-Unternehmen mit Sitz in Grimma, das von Dr. Andr\u00e9 Gerth gegr\u00fcndet wurde. Das Unternehmen arbeitet an einer klinischen Studie der Phase I\/IIa zur Marktzulassung eines humanen Stammzelltherapeutikums zur Behandlung von fokalen Knorpelsch\u00e4den am Kniegelenk. Die aus dem Nabelschnurgewebe extrahierten Stammzellen werden in eine kollagenhaltige Tr\u00e4germatrix eingebettet. In einem minimalinvasiven Eingriff setzt ein Chirurg die zellbeladene Matrix in den gesch\u00e4digten Knorpel ein. Das Zelltherapeutikum regt die Neubildung von Knorpelgewebe an und lindert Schmerzen und Entz\u00fcndung. Die Vision des Unternehmens ist es, k\u00fcnftig auch weitere Gelenke und andere Indikationen wie Arthrose mit innovativen Zelltherapien zu adressieren und so die Lebensqualit\u00e4t vieler Menschen deutlich zu verbessern.\u201c\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cfh.de\/en\/project\/tgfs-bioncart\/\" \/>\n<meta property=\"og:site_name\" content=\"CFH\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-28T17:00:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cfh.de\/wp-content\/uploads\/2025\/07\/Logo-BionCart.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2292\" \/>\n\t<meta property=\"og:image:height\" content=\"1375\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cfh.de\/project\/tgfs-bioncart\/\",\"url\":\"https:\/\/www.cfh.de\/project\/tgfs-bioncart\/\",\"name\":\"TGFS BIONCaRT GmbH - CFH\",\"isPartOf\":{\"@id\":\"https:\/\/www.cfh.de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cfh.de\/project\/tgfs-bioncart\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cfh.de\/project\/tgfs-bioncart\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cfh.de\/wp-content\/uploads\/2025\/07\/Logo-BionCart.png\",\"datePublished\":\"2025-07-21T15:46:16+00:00\",\"dateModified\":\"2025-07-28T17:00:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cfh.de\/project\/tgfs-bioncart\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cfh.de\/project\/tgfs-bioncart\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.cfh.de\/project\/tgfs-bioncart\/#primaryimage\",\"url\":\"https:\/\/www.cfh.de\/wp-content\/uploads\/2025\/07\/Logo-BionCart.png\",\"contentUrl\":\"https:\/\/www.cfh.de\/wp-content\/uploads\/2025\/07\/Logo-BionCart.png\",\"width\":2292,\"height\":1375},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cfh.de\/project\/tgfs-bioncart\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.cfh.de\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Projekte\",\"item\":\"https:\/\/www.cfh.de\/project\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"TGFS BIONCaRT GmbH\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cfh.de\/#website\",\"url\":\"https:\/\/www.cfh.de\/\",\"name\":\"CFH\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cfh.de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TGFS BIONCaRT GmbH \u2014&nbsp;CFH","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cfh.de\/en\/project\/tgfs-bioncart\/","og_locale":"en_US","og_type":"article","og_title":"TGFS BIONCaRT GmbH - CFH","og_description":"\u201eDie BIONCaRT GmbH ist ein Life-Science-Unternehmen mit Sitz in Grimma, das von Dr. Andr\u00e9 Gerth gegr\u00fcndet wurde. Das Unternehmen arbeitet an einer klinischen Studie der Phase I\/IIa zur Marktzulassung eines humanen Stammzelltherapeutikums zur Behandlung von fokalen Knorpelsch\u00e4den am Kniegelenk. Die aus dem Nabelschnurgewebe extrahierten Stammzellen werden in eine kollagenhaltige Tr\u00e4germatrix eingebettet. In einem minimalinvasiven Eingriff setzt ein Chirurg die zellbeladene Matrix in den gesch\u00e4digten Knorpel ein. Das Zelltherapeutikum regt die Neubildung von Knorpelgewebe an und lindert Schmerzen und Entz\u00fcndung. Die Vision des Unternehmens ist es, k\u00fcnftig auch weitere Gelenke und andere Indikationen wie Arthrose mit innovativen Zelltherapien zu adressieren und so die Lebensqualit\u00e4t vieler Menschen deutlich zu verbessern.\u201c","og_url":"https:\/\/www.cfh.de\/en\/project\/tgfs-bioncart\/","og_site_name":"CFH","article_modified_time":"2025-07-28T17:00:19+00:00","og_image":[{"width":2292,"height":1375,"url":"https:\/\/www.cfh.de\/wp-content\/uploads\/2025\/07\/Logo-BionCart.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cfh.de\/project\/tgfs-bioncart\/","url":"https:\/\/www.cfh.de\/project\/tgfs-bioncart\/","name":"TGFS BIONCaRT GmbH \u2014&nbsp;CFH","isPartOf":{"@id":"https:\/\/www.cfh.de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cfh.de\/project\/tgfs-bioncart\/#primaryimage"},"image":{"@id":"https:\/\/www.cfh.de\/project\/tgfs-bioncart\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cfh.de\/wp-content\/uploads\/2025\/07\/Logo-BionCart.png","datePublished":"2025-07-21T15:46:16+00:00","dateModified":"2025-07-28T17:00:19+00:00","breadcrumb":{"@id":"https:\/\/www.cfh.de\/project\/tgfs-bioncart\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cfh.de\/project\/tgfs-bioncart\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cfh.de\/project\/tgfs-bioncart\/#primaryimage","url":"https:\/\/www.cfh.de\/wp-content\/uploads\/2025\/07\/Logo-BionCart.png","contentUrl":"https:\/\/www.cfh.de\/wp-content\/uploads\/2025\/07\/Logo-BionCart.png","width":2292,"height":1375},{"@type":"BreadcrumbList","@id":"https:\/\/www.cfh.de\/project\/tgfs-bioncart\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.cfh.de\/"},{"@type":"ListItem","position":2,"name":"Projekte","item":"https:\/\/www.cfh.de\/project\/"},{"@type":"ListItem","position":3,"name":"TGFS BIONCaRT GmbH"}]},{"@type":"WebSite","@id":"https:\/\/www.cfh.de\/#website","url":"https:\/\/www.cfh.de\/","name":"CFH","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cfh.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/project\/44661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/comments?post=44661"}],"version-history":[{"count":8,"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/project\/44661\/revisions"}],"predecessor-version":[{"id":44705,"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/project\/44661\/revisions\/44705"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/media\/44703"}],"wp:attachment":[{"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/media?parent=44661"}],"wp:term":[{"taxonomy":"project_category","embeddable":true,"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/project_category?post=44661"},{"taxonomy":"project_tag","embeddable":true,"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/project_tag?post=44661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}